Search

everythinglearnresearchcommunity

for

Search:↓

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Men need tailored laser and energy-based cosmetic treatments.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Photodynamic therapy with methylene blue and a laser effectively destroys hair follicles better than traditional laser hair removal.

New compounds may help treat prostate issues without affecting androgen receptors.

Kolaviron and quercetin may help treat prostate issues.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The method accurately measures finasteride in skin after using special carriers.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The new drug delivery system effectively targets lung cancer cells.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.